Literature DB >> 16101482

Novel non-rodent models of kidney disease.

Dirk M Hentschel1, Joseph V Bonventre.   

Abstract

Kidney disease in the 21(st) century affects increasing numbers of individuals. We continue to be challenged by our lack of understanding of the pathophysiology of acute and chronic renal disease including genetic diseases involving the kidney. Rodent knockout animals or inbred strains have greatly contributed to our understanding of many monogenetic and complex diseases. Non-rodent animal models of disease have become more attractive since genomic data has become available for a variety of organisms that offer distinct advantages over mice and rats for ease in conducting high-throughput chemical or mutagenesis screens. It is thus timely to examine the physiology and pathophysiology of the kidney or kidney equivalents in these organisms to evaluate their relevance as models for human disease. In addition to organisms whose small size and accessibility facilitate large scale screening approaches, larger animals at the other end of the spectrum offer unique physiological advantages in both size equivalency to humans as well as, in some cases, physiological and pathophysiological responses that closely mimic those of humans. Here we review a selected number of non-rodent experimental models of kidney diseases, focusing on recent advances in the use of the worm Caenorhabditis elegans, the fruitfly Drosophila melanogaster, the zebrafish Danio rerio, the little skate Leucoraja erinacea, the MGH miniature swine, merino cross sheep, and the cow Bos taurus to study kidney disease.

Entities:  

Mesh:

Year:  2005        PMID: 16101482     DOI: 10.2174/1566524054553469

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  7 in total

1.  Characterization of low molecular weight chemical fractions of dry bean (Phaseolus vulgaris) for bioactivity using Caenorhabditis elegans longevity and metabolite fingerprinting.

Authors:  Meghan M Mensack; Vanessa K Fitzgerald; Matthew R Lewis; Henry J Thompson
Journal:  J Agric Food Chem       Date:  2010-06-09       Impact factor: 5.279

Review 2.  Fish and frogs: models for vertebrate cilia signaling.

Authors:  Oliver Wessely; Tomoko Obara
Journal:  Front Biosci       Date:  2008-01-01

3.  Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

Authors:  Jolene Zheng; Joseph R Vasselli; Jason F King; Michael L King; Wenqian We; Zachary Fitzpatrick; William D Johnson; John W Finley; Roy J Martin; Michael J Keenan; Frederic M Enright; Frank L Greenway
Journal:  Am J Ther       Date:  2016 Nov/Dec       Impact factor: 2.688

Review 4.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

5.  SkateBase, an elasmobranch genome project and collection of molecular resources for chondrichthyan fishes.

Authors:  Jennifer Wyffels; Benjamin L King; James Vincent; Chuming Chen; Cathy H Wu; Shawn W Polson
Journal:  F1000Res       Date:  2014-08-12

6.  Restoration of renal function in zebrafish models of ciliopathies.

Authors:  Jonathan L Tobin; Philip L Beales
Journal:  Pediatr Nephrol       Date:  2008-07-05       Impact factor: 3.714

7.  Optimizing porcine donor kidney preservation with normothermic or hypothermic machine perfusion: A systematic review.

Authors:  Sarah Bouari; Özgür Eryigit; Ron W F de Bruin; Jan N M IJzermans; Robert C Minnee
Journal:  Artif Organs       Date:  2021-07-26       Impact factor: 3.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.